PA
CATX icon

Profund Advisors’s Perspective Therapeutics CATX Stock Holding History

Profund Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
56,714
+15,147
+36% +$57.2K 0.01% 1101
2026
Q1 		$173K Buy
+41,567
New +$176K 0.01% 1047
2024
Q4 		– Sell
-20,261
Closed -$270K – 1119
2024
Q3 		$270K Buy
+20,261
New +$269K 0.01% 859

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Profund Advisors's CATX Position: Q2 2026 in Review

Profund Advisors increased its Perspective Therapeutics (CATX) stake by 36% in Q2 2026, buying an estimated $57.2K and bringing the position to 56,714 shares worth $193K. The position accounts for 0.01% of the portfolio, ranked #1101.

Profund Advisors first reported a position in CATX in Q3 2024 and has held it in 3 quarters since. The position peaked at $270K in Q3 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Profund Advisors held 56,714 shares of Perspective Therapeutics worth $193K as of Q2 2026.
  • Profund Advisors bought 15,147 Perspective Therapeutics shares in Q2 2026, an estimated $57.2K.
  • Perspective Therapeutics made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #1101 holding.
  • Profund Advisors first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Profund Advisors's Perspective Therapeutics position peaked at $270K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.